γ-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor κB activity

Experimental Biology and Medicine

Volumn 230, Issue 4, 2005, Pages 235-241

  Shah, Sumit J ^a   Sylvester, Paul W ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Akt; Breast cancer; NF B; Tocotrienols; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; GAMMA TOCOTRIENOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST EPITHELIUM; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 10; CHROMOSOME DELETION; COLORIMETRY; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOSIS RATE; TRANSCRIPTION INITIATION;

EID: 16444387293     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020523000402     Document Type: Article

References (35)

1. McIntyre BS, Briski, KP, Gapor A, Sylvester PW. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224:292-301, 2000.
2. Sylvester PW, Nachnani A, Shah S, Briski KP. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pacific J Clin Nutr 11:S452-S459, 2002.
3. Shah S, Gapor A, Sylvester PW. Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr Cancer 45:236-246, 2003.
4. Shah S, Sylvester PW. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Exp Biol Med 229:745-755, 2004.
5. McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A, Sylvester PW. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35:171-180, 2000.
6. Sylvester PW, McIntyre BS, Gapor A, Briski KP. Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation. Cell Prolif 34:347-357, 2001.
7. Imagawa W, Tomooka Y, Nandi S. Serum-free growth of normal and tumor mouse mammary epithelial cells in primary culture. Proc Natl Acad Sci U S A 79:4074-4077, 1982.
8. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990.
9. Wagstaff SC, Bowler WB, Gallagher JA, Hipskind RA. Extracellular ATP activates multiple signalling pathways and potentiates growth factor-induced c-fos gene expression in MCF-7 breast cancer cells. Carcinogenesis 21:2175-2181, 2000.
10. Hermanto U, Zong CS, Wang LH. ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth. Oncogene 20:7551-7562, 2001.
11. Biswas DK, Cruz AP, Gansberger E, Pardee AB. Epidermal growth factor-induced nuclear factor kappa B activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci U S A 97:8542-8547, 2000.
12. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629-3639, 1997.
13. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262-267, 1998.
14. Sliva D, Rizzo MT, English D. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem 277:3150-3157, 2002.
15. Varticovski L, Harrison-Findik D, Keeler ML, Susa M. Role of PI 3-kinase in mitogenesis. Biochim Biophys Acta 1226:1-11, 1994.
16. Vanhaesebroeck B, Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253:239-254, 1999.
17. Toker A. Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol Pharmacol 57:652-658, 2000.
18. Kandel ES, Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253:210-229, 1999.
19. Khwaja A. Akt is more than just a Bad kinase. Nature 401:33-34, 1999.
20. Baldwin AS Jr. The NF-kappaB and IkappaB proteins: new discoveries and insights. Annu Rev Immunol 14:649-683, 1996.
21. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356, 1999.
22. Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, Pardee AB. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci U S A 98:10386-10391, 2001.
23. Danielson KG, Anderson LW, Hosick HL. Selection and characterization in culture of mammary tumor cells with distinctive growth properties in vivo. Cancer Res 40:1812-1819, 1980.
24. Anderson LW, Danielson KG, Hosick HL. Metastatic potential of hyperplastic alveolar nodule derived mouse mammary tumor cells following intravenous inoculation. Eur J Cancer Clin Oncol 17:1001-1008, 1981.
25. Sylvester PW, Birkenfeld HP, Hosick HL, Briski KP. Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro. Exp Cell Res 214:145-153, 1994.
26. McIntyre BS, Birkenfeld HP, Sylvester PW. Relationship between epidermal growth factor receptor levels, autophosphorylation and mitogenic-responsiveness in normal mouse mammary epithelial cells in vitro. Cell Prolif 28:45-56, 1995.
27. Renard P, Emest I, Houbion A, Art M, Le Calvez H, Raes M, Remacle J. Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 29:E21, 2001.
28. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96(Pt 1):121-129, 1990.
29. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789, 1995.
30. Sylvester PW, Theriault A. Role of tocotrienols in the prevention of cardiovascular disease and breast cancer. Curr Top Nutraceutical Res 1:121-136, 2003.
31. Hernandez-Sotomayor SM, Carpenter G. Epidermal growth factor receptor: elements of intracellular communication. J Membr Biol 128:81-89, 1992.
32. Gordge PC, Hulme MJ, Clegg RA, Miller WR. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer 32A:2120-2126, 1996.
33. Xing C, Imagawa W. Altered MAP kinase (ERK 1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF. Carcinogenesis 20:1201-1208, 1999.
34. Kempna P, Zingg JM, Ricciarelli R, Hierl M, Saxena S, Azzi A. Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free Radic Biol Med 34:1458-1472, 2003.
35. Rohlff C, Glazer RI. Regulation of multidrug resistance through the cAMP and EOF signalling pathways. Cell Signal 7:431-443, 1995.